A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects

NCT01087645 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2
Healthy

Interventions

DRUG: NN9925 (oral)
DRUG: NN9925 (i.v.)
DRUG: placebo
DRUG: NN9925 (oral)
DRUG: placebo

Sponsor

Novo Nordisk A/S